EX-32.2 7 amph-20221231xex32d2.htm EX-32.2

Exhibit 32.2

​

CERTIFICATIONS OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

​

The undersigned officer of Amphastar Pharmaceuticals, Inc. (the “Company”), hereby certifies, to the best of such officer’s knowledge, that:

​

(i) the Annual Report on Form 10-K of the Company for the year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and

​

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

​

​

​

​

​

Date: March 1, 2023

By:

/s/ WILLIAM J. PETERS

​

​

​

William J. Peters

​

​

​

Chief Financial Officer

​

​

​

(Principal Financial and Accounting Officer)

​

​